Clari vs Gong for Outpatient PT Networks

A referral relationship with an orthopedic group or a primary care practice doesn't move through discovery, proposal, and close the way a software sale does. It's built over repeated visits, shared patient outcomes, and trust that accumulates slowly. Your business development liaisons know this instinctively, which is exactly why most of them have never logged a single interaction in a CRM: the relationship doesn't feel like a deal, so it doesn't get tracked like one.

That's not a failure of discipline so much as a mismatch between the tool and the motion. Before comparing Clari and Gong, you need a pipeline model built around referral volume and relationship health, not deal stages borrowed from a SaaS sales playbook.

The instinct when adopting any CRM is to force existing relationships into a standard stage model: prospecting, qualification, proposal, close. That model breaks immediately for referral relationships, since there's no proposal and no close date, just a referring physician who sends more or fewer patients your way over time depending on how the last several went.

A better model tracks referral volume per source over time and flags relationships trending down, alongside a separate track for payer contract negotiations, which genuinely do have stages and a real negotiation cycle. Keep those two tracks distinct rather than collapsing physician relationships into a sales funnel they were never built for.

Gong's value depends on recording calls and analyzing what was said. In a healthcare setting, any call that could touch patient information needs to be scoped so it never gets swept into that recording and analysis pipeline, and that scoping work has to happen before you evaluate the product itself, not after. A referral development call with a physician's office may well touch specific patients, referral patterns, or clinical outcomes, all of which raise the bar considerably above a typical B2B sales call.

Involve your compliance officer and legal counsel before any pilot, and be explicit about which calls are in scope and which are excluded entirely. If that scoping can't be done cleanly, Gong isn't worth the risk regardless of what it might add analytically.

Start with a simple, low-cost tracker: referral source, monthly referral volume, trend direction, and last contact date for each key relationship. Run that manually for a quarter and see whether it changes how your BD team prioritizes their visits. If it does, and the team actually uses it, that's the signal you're ready to formalize the tracking in a real system rather than a shared spreadsheet.

Payer contract negotiations deserve their own simple stage model: outreach, terms under discussion, contract drafted, signed. That side of the business behaves enough like a normal sales cycle that Clari's stage governance genuinely fits it, even where it doesn't fit referral cultivation.

Confirm your compliance posture on call recording before evaluating Gong at all, since that determines whether it's even usable in your organization. Ask whether your BD team will actually log referral visits and relationship notes consistently, since a pipeline tool with no input from the field is worthless regardless of vendor. And decide whether payer contract negotiations, which behave like a real sales cycle, are common enough to justify Clari's stage governance on their own, separate from the referral side of the business.

Before buying, work through these checks:

• Confirm your compliance posture on call recording before evaluating Gong at all, since that decides whether it is usable in your organization.
• Ask whether your BD team will log referral visits and relationship notes consistently, because a pipeline tool with no field input is worthless regardless of vendor.
• Decide whether payer contract negotiations should be tracked separately from physician referral outreach, since compliance scoping is usually cleaner for payer calls.
• Start with a simple tracker of referral source, monthly referral volume, trend direction, and last contact date before buying anything.

Referral volume only tells you demand is arriving, not whether your network can absorb it. A clinic already running near capacity can't convert a growing referral relationship into revenue as quickly as one with open appointment slots, so any serious forecast has to combine referral trend data with clinic-level capacity, not just track the referral side in isolation. Neither Clari nor Gong models this natively, since it's specific to a multi-site healthcare operation, so this piece has to be built into whatever tracker or CRM you settle on, usually as a simple capacity flag reviewed alongside referral trends each month.